FRA
PBH icon

Front Row Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Front Row Advisors’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-108
Closed -$4K – 984
2020
Q2 		$4K Hold
108
– – ﹤0.01% 704
2020
Q1 		$4K Buy
+108
New +$4.2K ﹤0.01% 678

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Front Row Advisors's PBH Position: Q3 2020 in Review

Front Row Advisors sold out of Prestige Consumer Healthcare (PBH) in Q3 2020, closing a stake of 108 shares — an estimated $4K sold.

Front Row Advisors first reported a position in PBH in Q1 2020 and held it in 2 quarters. The position peaked at $4K in Q2 2020. 242 funds tracked by Wall St. Rank hold PBH as of Q3 2020.

  • Front Row Advisors reported no remaining Prestige Consumer Healthcare position as of Q3 2020 after selling out during the quarter.
  • Front Row Advisors sold 108 Prestige Consumer Healthcare shares in Q3 2020, an estimated $4K.
  • Front Row Advisors first reported a position in Prestige Consumer Healthcare in Q1 2020 and held it in 2 quarters.
  • Front Row Advisors's Prestige Consumer Healthcare position peaked at $4K in Q2 2020.
  • 242 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2020.

Based on Front Row Advisors's 13F filing for Q3 2020, filed 30 Nov 2020.